Clincosm LogoSign in Get a demo

healthy adult subjects

Showing 1 - 25 of 55
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Adult Subjects Trial in San Antonio (TTYP01, Radicava, Radicava ORS)

Recruiting
  • Healthy Adult Subjects
  • San Antonio, Texas
    ICON Early Phase Services
Oct 24, 2023

Healthy Adult Subjects Trial in Seoul (ID110521156, Placebo of ID110521156)

Not yet recruiting
  • Healthy Adult Subjects
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Sep 26, 2023

Healthy Adult Subjects Trial in Hefei (Test drug (T1): CBP-201 injection (pre-filled syringe, 150 mg/1 mL), Test drug (T2):

Not yet recruiting
  • Healthy Adult Subjects
  • Test drug (T1): CBP-201 injection (pre-filled syringe, 150 mg/1 mL)
  • +2 more
  • Hefei, Anhui, China
    The Second Hospital of Anhui Medical University
Jun 14, 2023

Healthy Adult Subjects Trial in Tempe (Omaveloxolone, Efavirenz)

Not yet recruiting
  • Healthy Adult Subjects
  • Tempe, Arizona
    Celerion, Inc.
Jun 16, 2023

Healthy Adult Subjects Trial in Christchurch (AVT05, Simponi)

Recruiting
  • Healthy Adult Subjects
  • AVT05
  • Simponi
  • Christchurch, New Zealand
    New Zealand Clinical Research
Jan 13, 2023

Healthy Adult Subjects, Sickle Cell Disease Trial in Little Rock, Atlanta, Overland Park (FTX-6058/ oral capsule(s), FTX-6058 -

Completed
  • Healthy Adult Subjects
  • Sickle Cell Disease
  • FTX-6058/placebo oral capsule(s)
  • +2 more
  • Atlanta, Georgia
  • +1 more
Dec 9, 2022

Healthy Adult Subjects Trial in Beijing (CRB4101, Placebo)

Recruiting
  • Healthy Adult Subjects
  • Beijing, Beijing, China
    Peking University Third Hospital
Nov 29, 2022

Healthy Adult Subjects Trial in Sydney (TNM002 Dosage 1 (10 µg/kg), Placebo, TNM002 Dosage 2 (35 µg/kg))

Completed
  • Healthy Adult Subjects
  • TNM002 Dosage 1 (10 μg/kg)
  • +4 more
  • Sydney, New South Wales, Australia
    Scientia Clinical Research
Nov 2, 2022

Healthy Adult Subjects, Pharmacokinetics, Safety and Tolerability Trial in Baltimore (Low dose KT07, High dose KT07, Low dose

Completed
  • Healthy Adult Subjects
  • +2 more
  • Low dose KT07
  • +3 more
  • Baltimore, Maryland
    Pharmaron
Oct 13, 2022

Healthy Adult Subjects Trial in Melbourne (CBP-174, Placebo)

Completed
  • Healthy Adult Subjects
  • Melbourne, Victoria, Australia
    Nucleus Network Pty Ltd
Aug 9, 2022

Healthy Adult Subjects Trial in Tokyo (MT-1186)

Completed
  • Healthy Adult Subjects
  • Tokyo, Japan
    Investigational site
Apr 19, 2022

Healthy Adult Subjects Trial in Qingdao (CuminUP30, Curcumin capsules)

Recruiting
  • Healthy Adult Subjects
  • Qingdao, Shanndong, China
    Phase I Clinical Research Center
Apr 18, 2022

Healthy Adult Subjects Trial in Toshima-ku (TS-172, Placebo)

Completed
  • Healthy Adult Subjects
  • Toshima-ku, Japan
    Taisho Pharmaceutical Co., Ltd selected site
Apr 11, 2022

Healthy Adult Subjects Trial in Suzhou (CBP-307)

Completed
  • Healthy Adult Subjects
  • Suzhou, Jiangsu, China
    Connect Investigative Site
Apr 2, 2022

Healthy Adult Subjects Trial in Austin (Losmapimod 15 mg oral tablet, Losmapimod two 7.5 mg oral tablets, Losmapimod one 15 mg

Completed
  • Healthy Adult Subjects
  • Losmapimod 15 mg oral tablet
  • +2 more
  • Austin, Texas
    PPD Phase I Clinic
Nov 11, 2021

Healthy Adult Subjects Trial in Beijing (Famitinib malate)

Completed
  • Healthy Adult Subjects
  • Famitinib malate
  • Beijing, Beijing, China
    Xuanwu Hospital Beijing, Capital Medical University
Oct 19, 2021

Obstructive Hypertrophic Cardiomyopathy, Healthy Adult Subjects Trial in Beijing (CK-3773274, Placebo)

Completed
  • Obstructive Hypertrophic Cardiomyopathy
  • Healthy Adult Subjects
  • Beijing, Beijing, China
    Clinical Site
Sep 12, 2021

Healthy Adult Subjects Trial in Qingdao (CuminUP60®, Curcumin capsules)

Completed
  • Healthy Adult Subjects
  • Qingdao, Shangdong, China
    Phase I Clinical Research Center
Aug 3, 2021

Healthy Adult Subjects Trial in Nantes (T2309, Nutrof Total)

Completed
  • Healthy Adult Subjects
  • T2309
  • Nutrof Total
  • Nantes, France
    Centre Investigation Clinique
Jul 27, 2021

Healthy Adult Subjects Trial in Tokyo (MT-1186)

Completed
  • Healthy Adult Subjects
  • Tokyo, Toshima-ku, Japan
    Investigational site
May 12, 2021

Healthy Adult Subjects Trial in Adelaide (TTYP01 single ascending doses, Placebo, TTYP01, 60 mg)

Completed
  • Healthy Adult Subjects
  • TTYP01 single ascending doses
  • +6 more
  • Adelaide, South Australia, Australia
    CMAX Clinical Research Pty Ltd
Mar 31, 2021

Healthy Adult Subjects, Healthy Elderly Subjects Trial in South Miami (BIIB118, Melatonin)

Completed
Has Results
  • Healthy Adult Subjects
  • Healthy Elderly Subjects
  • South Miami, Florida
  • +1 more
Feb 15, 2021

Healthy Adult Subjects Trial in Changsha (SHR2554 and Itraconazole)

Completed
  • Healthy Adult Subjects
  • SHR2554 and Itraconazole
  • Changsha, Hunan, China
    Xiangya Hospital of Central South University
Nov 12, 2020

Healthy Adult Subjects Trial in Berlin (Roxadustat)

Completed
  • Healthy Adult Subjects
  • Berlin, Germany
    Site DE49001
Oct 8, 2020

Healthy Adult Subjects Trial in Qingdao (Famitinib capsule, Rifampicin capsule)

Completed
  • Healthy Adult Subjects
  • Famitinib capsule
  • Rifampicin capsule
  • Qingdao, Shandong, China
    Affiliated Hospital of Qingdao University
Sep 27, 2020